Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

Clinical trial NCT00031694 · COMPLETED

Trial details

NCT number: NCT00031694
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2002-03-01
Primary completion: 2010-04-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.